Company intelligence / Profile preview

Emulseo

Bordeaux, Nouvelle-Aquitaine, France

Ownership: Private
Employees: ~1
Development stage: Other

Overview

Emulseo supplies ISO 9001–certified, high-purity surfactant and oil formulations (such as FluoSurf and Fluo-Oil) for droplet-based microfluidics, validated in demanding biotech and healthcare research applications including single-cell RNA-seq, digital PCR, and high-throughput screening. Its products are used by leading research teams worldwide and in collaborations with industry leaders.

Therapeutic areas: OtherInfectious DiseasesImmunology
Modalities: DevicePolymerChemical reagent
Industry: Chemicals & Materials

Partnerships

Syensqo (strategic partnership for fluorinated oils in microfluidics)Micronit (collaborative chip applications)LiveDrop (ModaFlow system compatibility)

Beyond the preview

Go deeper on Emulseo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Emulseo.

Explore the full profile